{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:41:53Z","timestamp":1773405713879,"version":"3.50.1"},"reference-count":46,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,10,24]],"date-time":"2005-10-24T00:00:00Z","timestamp":1130112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Administration of immunosuppressive treatment in hepatitis B virus carriers with malignancies is associated with the risk of hepatitis B reactivation. This complication is more frequent in patients with hematologic malignancies because administration of corticosteroids, the mainstay of treatment of these patients, is an independent risk factor for hepatitis B reactivation. When lamivudine is given prior to chemotherapy, it prevents the viral replication during the immunosuppression period; therefore, it might reduce the risk of hepatitis B exacerbation. We performed a prospective study to assess the efficacy of prophylactic administration of lamivudine in this setting. Ten hepatitis B virus carriers with hematologic malignancies were included in this study; seven were HBsAg positive, and three had isolated antiHBc and detectable HBV\u2010DNA levels. Nine patients were given corticosteroids after the administration of lamivudine. Lamivudine was given per os at a dose of 100 mg once daily. In four patients that had not been previously treated with chemotherapy, lamivudine was started 19 days (median) (range, 0\u201335 days) prior to the onset of chemotherapy. The administration of lamivudine has not stopped since in any of our patients. After a median follow\u2010up of 15 months (range 6\u201338 months), no hepatitis B reactivation was observed. HBV\u2010DNA levels were decreased in all 6 patients who had detectable HBV\u2010DNA at baseline. Lamivudine was well tolerated. Chemotherapy regimens were administered as planned, and their effectiveness was not compromised by lamivudine. In conclusion, prophylactic administration of lamivudine should be considered as a means of reducing the frequency of hepatitis B reactivation in hepatitis B virus carriers with hematologic malignancies who are being treated with chemotherapy. Am. J. Hematol. 80:197\u2013203, 2005. \u00a9 2005 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.20471","type":"journal-article","created":{"date-parts":[[2005,10,24]],"date-time":"2005-10-24T15:47:48Z","timestamp":1130168868000},"page":"197-203","source":"Crossref","is-referenced-by-count":34,"title":["Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy\u2014A prospective case series"],"prefix":"10.1002","volume":"80","author":[{"given":"Themistoklis","family":"Vassiliadis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilia","family":"Garipidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tziomalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Perifanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Giouleme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Vakalopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,24]]},"reference":[{"issue":"1","key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/annonc\/8.suppl_1.S107","article-title":"Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan","volume":"8","author":"Kumagai K","year":"1997","journal-title":"Ann Oncol"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0"},{"key":"e_1_2_1_5_2","first-page":"2925","article-title":"Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients","volume":"46","author":"Markovic S","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90599-G"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.394"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01364.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03099.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1182\/blood.V87.3.1202a.bloodjournal8731202a","article-title":"Steroid\u2010free chemotherapy decreases the risk of hepatitis flare\u2010up in hepatitis B virus carriers with non\u2010Hodgkin lymphoma","volume":"87","author":"Cheng AL.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_1_11_2","first-page":"360","article-title":"Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies","volume":"21","author":"Ohtsu T","year":"1991","journal-title":"Jpn J Clin Oncol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008206519571"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690652"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00808.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250144"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807093390201"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510263331710"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(92)90513-2"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03239.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<263::AID-JMV1>3.0.CO;2-X"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702804"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050510"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01847.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10084"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.2.391"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50220"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199010000-00015"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199004000-00011"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)90897-1"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-4-447"},{"key":"e_1_2_1_31_2","first-page":"911","article-title":"Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients","volume":"73","author":"Lau JY","year":"1989","journal-title":"Q J Med"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900215)65:4<878::AID-CNCR2820650409>3.0.CO;2-K"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296569"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900080504"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910213411702"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000046630"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(85)80002-0"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-2-95"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007532"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80307-3"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2003.00479.x"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1080\/08880010490273019"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10043"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270628"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005350170049"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2001.067001045.x"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(89)90012-3"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.20471","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.20471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T15:29:23Z","timestamp":1696692563000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.20471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,24]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1002\/ajh.20471"],"URL":"https:\/\/doi.org\/10.1002\/ajh.20471","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,24]]}}}